The global Anti-VEGF Market is witnessing moderate growth, driven by the increasing prevalence of retinal disorders, rising geriatric population, and growing demand for advanced ophthalmic treatments. According to the latest report by Straits Research, the market was valued at USD 12.36 billion in 2023 and is projected to reach USD 13.54 billion by 2032, expanding at a compound annual...
English
Indonesia
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek